Concepedia

Hugh Zhu

HZ

Statistics

Publications

18

Citations

1.5K

H-Index

14

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Novartis (China)

Novartis Institutes for BioMedical Research

Northwestern University

Novartis (Switzerland)

Hugh Zhu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

1989–2020

18

Publications

18

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors

Thierry Fischmann, Catherine K. Smith, Todd Mayhood et al. · Biochemistry · 2009 · 178 citations

Life Sciences, Biochemistry, Molecular Biology +17

Rhodium-Catalyzed Alkyne Cyclotrimerization Strategies for C-Aryl Glycoside Synthesis

Frank E. McDonald, Hugh Zhu, Christopher R. Holmquist · Journal of the American Chemical Society · 1995 · 124 citations

Natural Sciences, Chemistry, Carbohydrate Chemistry +8

Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy

Rajesh Krishna, Barry Gumbiner, C. Melinda Stevens et al. · Clinical Pharmacology & Therapeutics · 2009 · 87 citations

Medicine, Endocrinology, Pharmacology +17

Novel Strategy for Oligosaccharide Synthesis Featuring Reiterative Alkynol Cycloisomerization

Frank E. McDonald, Hugh Zhu · Journal of the American Chemical Society · 1998 · 63 citations

Pharmacy, Biochemistry, Chemistry +6

1–5 of 18